Current guidelines recommend initiating hypertension treatment with fixed-dose combinations, and adding statins based on cardiovascular risk, to improve adherence and efficacy.
Supports guideline-endorsed fixed-dose combinations; leaves open need for randomized outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Barbora Nussbaumerová (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: